|Presented by: Michael Vozniak, PharmD BCOP|
|The Abramson Cancer Center of the University of Pennsylvania|
Continuing Education Information
This continuing education activity is designed for nurses and nurse practitioners in clinical practice to learn about chemotherapy and biotherapeutic agents approved by the US FDA in 2012. This activity has been approved for 1.0 contact hour (and 0.75 pharmacology hours) by the Hospital of the University of Pennsylvania, Department of Nursing Development and Education, an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
To receive continuing education credits for this activity:
The presenters and planning committee report no conflicts of interest.
The educational objectives of this activity are: